Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 46 No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Ranga Krishnan, MB, ChB: Evidence-Based Decision-Making in Psychopharmacology
1
x
$
30.00
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
2
x
$
30.00
Naomi M. Simon, MD: Bupropion Sustained Release for Panic Disorder
1
x
$
30.00
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
1
x
$
30.00
Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity
1
x
$
30.00
Assessment of the Correlation Between Unipolar and Bipolar Depression, Calcium Levels, Thyroid Function, and Inflammatory Markers: A Pilot Cross-Sectional Study
1
x
$
30.00
Demographic Variation in the Use of Prazosin for Treatment of Sleep Disturbance in Combat Veterans with PTSD
1
x
$
30.00
Oncology Ethics: Forum The Expanding Indications for Preimplantation Genetic Diagnosis
1
x
$
0.00
Psychopharmacology Bulletin VOL 37 Supplement No. 1 - Full Issue Stacked PDF
1
x
$
60.00
Quetiapine XR Negative Clinical Trials Report by Gang Wang
1
x
$
30.00
Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder
1
x
$
30.00
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
1
x
$
30.00
Alisa B. Busch - Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
1
x
$
30.00
VOL 3 No. 5 Full Issue - May 2001
1
x
$
20.00
Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
1
x
$
30.00
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
1
x
$
30.00
Psiquiatría y Salud Integral: afronta la psiquiatría geriátrica
1
x
$
0.00
Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression
1
x
$
30.00
VOL 1 No. 2 Full Issue - September 1999
1
x
$
20.00
View Cart
Checkout
Home
Store
“VOL 1 No. 2 Full Issue – September 1999” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment
$
30.00
Add to cart
Details
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
$
30.00
Add to cart
Details
A Bell’s Palsy Case Probably Related to Sertraline Use
$
30.00
Add to cart
Details
The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles
$
30.00
Add to cart
Details
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 46 No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
The Black Book of Psychotropic Dosing and Monitoring
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
$
30.00
Add to cart
Details
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains
$
30.00
Add to cart
Details
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 37 Supplement No. 2 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine
$
30.00
Add to cart
Details
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
Previous
1
2
3
4
…
44
Next
Page load link
Go to Top
